Werewolf Therapeutics (HOWL) stock exploded higher on Friday morning after management said the company has agreed to a definitive all-stock merger with Ambros Therapeutics. The combined company will pivot to focus on Ambros' Phase 3 drug candidate – neridronate – for Complex Regional Pain Syndrome…
ONLY AVAILABLE IN PAID PLANSThe dark lord – or someone dressed like him – said the technology would aid the empire in tracking ‘rebel scum’
Solowin Holdings marks 10th anniversary of operations
The TSX is at record highs, and Suncor could still be a smart buy if cash flow stays strong.
In a new research report, scientists at Johns Hopkins Medicine say they have developed a technology that allows them to capture a 3D molecular "snapshot" of hu…
Plus, it packs away to pocket size!
Beijing’s growing engagement comes as Washington’s presence in the region remains comparatively limited.